Purpose: To examine the long-term effects of a patient navigation (PN) program for mammography screening tailored to refugee women and to assess screening utilization among these women after PN ended. Methods: We assessed the proportion of patients completing mammography screening during the prior 2 years during 2012-2016 for refugee women who had previously received PN compared with that of English-speaking women cared for at the same health center during the same period, both overall and stratifying by age. We used logistic regression to compare screening completion between refugees and English speakers, adjusting for age, race, insurance status, number of clinic visits, and clustering by primary care physician and to test trends in screening over time. Results: In 2012, the year when the funding for PN ceased, among 126 refugee women eligible for breast cancer screening, mammography screening rates were significantly higher among refugees (90.5%, 95% confidence interval [CI]: 83.5-94.7%) than among English speakers (81.9%, 95% CI: 76.2-86.5%, p = 0.006). By 2016, screening rates decreased among refugee women (76.5%, 95% CI: 61.6-86.9%, p = 0.023) but were not statistically significantly different from those among English-speaking women (80.5%, 95% CI: 74.4-85.3%, p = 0.460). Screening prevalence for refugee women remained above the pre-PN program screening levels, and considerably so in women <50 years. Conclusion: The culturally and language-tailored PN program for refugee women appeared to have persistent effects, with refugee women maintaining similar levels of mammography screening to English-speaking patients 5 years after the PN program's end.
Introduction
Although mammography screening is widely available in the United States, 1 there are significant racial/ethnic disparities in breast cancer survival [2] [3] [4] [5] and mortality. 3, 6, 7 Immigrants, nonnative English speakers, and lowincome women are more often diagnosed with breast cancer at a late less treatable stage, 4, [8] [9] [10] [11] [12] [13] [14] [15] due, in part, to lower utilization of mammography screening. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Refugees, who have all of these characteristics, are a particularly disadvantaged population likely to face numerous barriers to care and screening and face unique challenges. 18, [26] [27] [28] Refugees tend to delay screening and are more likely to have never had a mammogram compared with nonrefugee immigrants. 26, 29, 30 Disparities in refugee screening can be due to lack of knowledge of preventive health, lack of exposure to health professionals in their home countries, the impact of war on health systems, as well as fear of medical procedures and racial discrimination. [31] [32] [33] [34] [35] [36] [37] [38] [39] Many refugees suffer from post-traumatic stress disorder resulting from the events surrounding their emigration, which can consequently make refugees particularly vulnerable to disparities in health. 16 Patient navigation (PN) has been shown to reduce disparities in cancer screening and follow-up. [40] [41] [42] Our group, as well as others, has demonstrated that PN screening programs in refugee communities can address and ultimately eliminate disparities in mammography screening rates in the short term. 27, 43, 44 The 3-year program at Massachusetts General Hospital Chelsea HealthCare Center (MGH Chelsea) used culturally and linguistically tailored navigators to reach out to Bosnian, Somali, and Arabic refugee women and navigated them to obtain breast cancer screening. PN promoted mammography screening in refugee populations and consequently increased mammography rates to levels equivalent to those measured in nonimmigrant and native English-speaking populations. 43 However, securing funding for patient navigators outside of a research setting can be a considerable challenge, and the MGH Chelsea navigation program ended after the research program concluded. It is unclear to what extent short-term navigation yields stable and sizable improvements in screening utilization in vulnerable populations.
The purpose of the study is to determine whether the PN program's reduction of screening disparities has persisted for an additional 5 years in the cohort of refugee participants from the previous study. Our study evaluates whether benefits of a 3-year PN program extend beyond the length of the actual program.
Methods
Details of the PN program among refugee women have been published previously. 43 In brief, the refugee PN program began in April 2009 at MGH Chelsea, when participants were introduced to the PN program with culturally and linguistically appropriate educational materials about breast cancer screening. Later, a navigator matched by culture and language background contacted the patient by phone or in person. Navigators worked to remove patients' individual psychological and logistical barriers to screening. Navigators educated women about breast cancer and screening, helped to schedule appointments, called participants about appointments, organized logistics, addressed insurance issues, and even accompanied them to radiology suite for testing. The PN program funding ceased on March 31, 2012.
Our study period extended 5 years from 2012, the year the PN program ended, through 2016. Women were defined as eligible for screening if they were 40 years of age or older, had not undergone mastectomy, and continuously had a primary care physician at MGH Chelsea. The primary study outcome was the proportion of patients who completed a mammogram during the prior 2 years. Screening proportions among refugees were compared with screening proportions among English-speaking patients cared for at MGH Chelsea in 2012. Patients were included in analyses for each year in which they remained primary care patients at MGH Chelsea. Data on completion of mammograms were obtained from electronic medical records and billing records. The Partners HealthCare Institutional Review Board approved this study.
We tabulated and compared patient characteristics between the groups at baseline. For each calendar year, we compared the proportion of patients completing mammography screening during the prior 2 years among refugee women with that among Englishspeaking patients. In addition, we examined the primary outcome stratified by patient age (40-49 and ‡50 years) since United States Preventative Services Task Force screening recommendations differ for these two age groups. We used logistic regression to compare the differences in the proportions completing screening with the generalized estimating equations procedure to account for clustering by primary care physician (PROC GENMOD, SAS version 9.2; SAS Institute, Cary, NC). To control for differences in patient characteristics among groups, patient age, race, insurance status, and the number of clinic visits over the prior 3 years were included in the models as covariates. In addition, we tested the trends in screening rates from 2012 through 2016 for refugees and English speakers using a difference in differences analysis, testing the interaction of time and group, accounting for clustering by primary care physician and adjusting for the mentioned covariates (PROC GLIMMIX). All statistical tests were two sided with an alpha of 0.05.
Results
In the baseline year, 2012, there were 126 refugee women eligible for breast cancer screening. Since our study population of refugees consisted of those who remained from the original PN study, the number of eligible refugee women can only remain the same or diminish every year as participants discontinued their use of the clinic or had mastectomies. Ninety-eight refugee women were patients at the study clinics during all 5 years of the study period. insurance and had different racial distributions than English-speaking women (Table 1) . In 2012 when the PN program ended, mammography screening proportions were significantly higher among refugee women (90.5%, 95% confidence interval [CI]: 83.5-94.7%) than among English-speaking women (81.9%, 95% CI: 76.2-86.5%, p = 0.006). After the PN program ended, the proportion of refugee women screened declined over time. There was a significant difference in the trends in screening rates over time for refugee women and English-speaking women ( p = 0.023). Although screening proportions among the English-speaking group did not change significantly over the 5-year period, screening rates among refugee women declined over time to 76.5% in 2016 (76.5%, 95% CI: 61.6-86.9. However, this rate was not statistically different from the screening proportion among English-speaking women (80.5%, 95% CI: 74.4-85.3%, p = 0.460) (Fig. 1) .
Stratifying results by patient age revealed that younger women (40-49 years) had a higher baseline prevalence of screening completion (96.4%) than the older ( ‡50 years) refugee women (86.8%), although both groups saw their screening completion prevalence decrease by a similar magnitude over the 5 years post-PN (11.9% for the ‡50 age group and 9.1% for the 40-49 age group). Among 40-49-year old women, screening prevalence was no different for refugees and nonrefugees, whereas for women aged 50 and older, screening prevalence was no different for refugees and English speakers. The greatest disparity in screening prevalence was seen among women of ages ‡50 years (Table 2) .
Discussion
We evaluated the persistence of reductions in disparities in breast cancer screening among refugee women for 5 years after a PN program's termination. We generally found decreases in screening completion for previously navigated refugee women in each year after the PN program ended, as is expected for periods after a PN program's end. 45 However, in the fifth year after the PN program ended (2016), screening completion prevalence for refugee women was comparable with that of Englishspeaking primary care patients, and remained well above the prevalence of screening for refugee women before the PN program (76% vs. 64%). 43 Screening rates for English-speaking women remained relatively stable over time, ranging from 77-82% in 2008-2011, 43 and ranging from 81-85% for the years 2012-2016 after the refugee PN program's end. Our results suggest that even short-term PN interventions can have lasting effects.
Although multiple studies have documented effectiveness of PN for improving mammography screening utilization, 40, 41, 43, [45] [46] [47] [48] to our knowledge no studies have documented outcomes after the program's end. It is well recognized that PN programs can be hard to maintain once research funding expires, and PN is typically not covered by health insurance, so PN programs need to be funded by research grants, philanthropic funds, or institutions. 49 These insights into trends after PN program termination are important, particularly since one-time or limited duration interventions tend to be considerably less expensive than more involved continuous interventions. 50 Previous studies have shown that even limited screening navigation interventions can have significant effects. 50, 51 Furthermore, the lasting effect after a program's end can play a great role in cost-effective calculations, since we show benefits of such a program can extend past the program's duration, and may be useful for assessing whether PN programs should be reimbursed as part of the routine care of vulnerable populations. PN may have persistent benefits due to increased patient knowledge about the importance of screening and familiarity with the mammography screening process. In addition, once patients receive a mammogram, radiology facilities at our site send letters to remind women when they are due for another mammogram, which may increase screening utilization.
The strengths of this study include our focus on refugee women, a particularly underserved and difficult to 52 In our health system, primary care patients due for mammography screening received mailed reminders encouraging screening, which may partially account for high screening rates in our population. 53 In addition, the decreasing number of refugees remaining in the sample each year decreased power to reject our null hypotheses as well as progressively increased the width of our prevalence CIs.
We cannot be certain that the PN program had truly persistent effects or whether comparable screening prevalence among refugee and nonrefugee women several years later reflects gradual acculturation into the health care system. A randomized study with a control group of non-navigated refugee women would be needed to determine whether screening participation among refugee women would increase to the levels of nonrefugee women over time without PN. Refugee women in our study had been in the United States for varying lengths of time. Bosnian refugees began arriving in the late 1990s, Somali immigrants began arriving around 2002, and Arabic-speaking refugees began arriving around 2005. In our prior study, PN was effective in increasing mammography screening among all three groups. 43 Finally, the persistent effect of PN we observed for mammography screening may not extend to PN programs that focus on follow-up of abnormal screening tests or cancer treatment.
Conclusion
The culturally and language-tailored PN program designed to reduce disparities in breast cancer screening among refugees appeared to have some lasting effect. Refugee women maintained higher prevalence of mammography completion compared with before PN and had screening rates similar to English-speaking women 5 years after the PN program's completion. The study revealed interesting trends in screening after the end of a PN program that could inform future program designs.
Health equity implications
These findings suggest that culturally and languagetailored PN programs can have lasting positive effects on the women they serve. Refugee women are an underserved and vulnerable group within our society, who may be in particular need of the support provided through PN. The long-term benefits of PN observed in our study suggest that one time navigation might improve cancer outcomes over the long term.
